IPD ImpediMed Limited

—Mkt Cap: —P/E: —

ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally…

Key Statistics

Company
Market Cap—
Enterprise Value16.09M USD
Revenue (TTM)10.10M USD
Gross Profit8.83M USD
Net Income (TTM)-17.21M USD
Revenue/Share0.0070 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees66
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU000000IPD8
Valuation
P/E (Trailing)—
P/E (Forward)-3.24
PEG—
EV/EBITDA-1.10
EV/Revenue1.59
P/S1.50
P/B2.00
EPS (TTM)-0.01
EPS (Forward)-0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin87.39%
Oper. Margin-146.22%
EBITDA Margin-144.63%
Profit Margin-170.44%
ROE-244.50%
ROA-71.86%
Growth
Revenue Growth5.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.34M USD
CapEx (TTM)878.37K USD
FCF Margin-97.45%
FCF Yield—
Net Debt905.32K USD
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity1.63
Current Ratio3.81
Quick Ratio3.23
Book Value/Sh0.0030 AUD
Cash/Share0.0040 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.0209 AUD
Target Range0.0086 AUD – 0.0400 AUD
# Analysts4
Ownership
Shares Out.3.66B
Float3.21B
Insiders9.20%
Institutions21.05%
Technical
SMA 500.0053 AUD
SMA 2000.0116 AUD
Beta1.07
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)6.01M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—